HAI Control Market - Market Research, Industry Trends, Market Share


Published: 02/22/2017
Pages: 242
Full Study Price: US$ 4,500

Hospital Acquired Infection (HAI) Control Markets provides in-depth discussion regarding the market for prevention, testing, and treatment of infections in the context of healthcare environments. Particular focus is given to bacterial bosocomial infections considering these are the most common infection types to spread in the healthcare delivery setting.

Hospital Acquired Infection (HAI) Control Markets provides a market analysis for the areas of prevention, testing, and treatment. The report provides market data which include: the global market for hospital infection control, 2010-2021; the global market for hospital infection prevention equipment and consumables, 2010-2021; the global market for hospital infection prevention; market value for infection prevention equipment and related consumables by product type, 2016; market value for infection prevention equipment and related consumables by technology, 2016; and much more.This report contains market analysis which primarily considers the epidemiological considerations as well as the patient group sizes both in the U.S. and worldwide when available.

Our Simple Buying Process

Choose License and Add
This Report To Your Cart.

Register, Checkout
and Verify Payment.

Receive Notification When
Your Report Is Available.

Table Of Contents

  • Executive Summary
    • Overview
    • The Nosocomial Infection
      • Table Frequency of the Most Common Nosocomial Infections
    • Market Scope
    • Research Methodology
    • Industry Challenges
      • Table Growth Drivers and Inhibitors
    • Total Size and Growth of the Market
      • Table The Global Market for Hospital Infection Control, 2010-2021
      • Table Global Market for Hospital Infection Control, 2010-2021: Market Continues to Show Moderate Growth over Period
    • Issues and Trends Affecting Market
  • Introduction and Industry Trends
    • Overview
      • Introduction to Pathogens
      • Classification of Antibacterial Organisms
    • Common Hospital (Nosocomial) Infections
    • Description of Infections
      • Acinetobacter Baumannii
      • Clostridium Difficile
      • Gastroenteritis
      • Hospital-Acquired Pneumonia (HAP)
      • Pseudomonas Aeruginosa
      • Staphylococcus Aureus/Methicillin-Resistant Staphylococcus Aureus
      • Stenotrophomonas Maltophilia
      • Tuberculosis
      • Urinary Tract Infections
      • Vancomycin-Resistant Enterococcus
      • Ventilator-Associated Pneumonia (VAP)
      • Patient Risk Factors
      • General Populations at Risk for Infection
        • Table Global Population at Risk for Serious Bacterial Infections, Secondary to Chronic Diseases by Selected Geographical Region
    • World Demographics
      • Table The Global Population, 2005-2050 (in millions)
      • Table Global Population Trends Age 65+, 2000-2050
      • Assessing the Problem: Nosocomial Infection Statistics
        • Table U.S. Hospital Admissions and Percent of Hospital Acquired Infections (HAIs)
        • Table European Union Hospital Admissions and Percent of Hospital Acquired Infections (HAIs)
      • Hospital Length of Stay
    • U.S. Government's National Plan to Prevent Healthcare Associated Infections (HAIs)
    • Steering Committee
    • Epidemiology and Laboratory Capacity for Infectious Diseases
    • Affordable Care Act (ACA) Funding
    • Emerging Infections Program
      • Table U.S. States ACA HAI Prevention Infrastructure Funding Awards, 2013-2016
    • The Department of Health and Human Services: 2017 Budget Highlights
      • Table U.S. Department of Health & Human Services Fiscal Budget, 2015-2017 ($millions)
    • National Healthcare Safety Network
      • Table U.S. Hospital Acquired Infection Standardized Infection Ratio (SIR), 2010-2014
      • Table U.S. Hospital Acquired Infection Standardized Infection Ratio (SIR) 2012 through 2014: MRSA, CLABSI, and CAUTI Infections Down; SSI and C. Diff Infections Up
    • Healthcare Infection Surveillance Process
    • Pharmaceutical Manufacturer and Marketer Trends
      • Trends in Partnerships and Alliances
      • Developers Trends
  • Infection Prevention
    • Overview
      • Table Methods of Sterilization and Disinfection
    • Market Overview
      • Table The Global Market for Hospital Infection Prevention Equipment and Consumables (Sterilization/Disinfection), 2010-2021
      • Healthcare Infection Prevention Market by Geographical Region
        • Table The Global Market for Hospital Infection Prevention (Sterilization/Disinfection) Estimated Products Sales by Primary Geographic Region, 2010-2021
      • Methods of Transmission
    • High-Risk Facilities or Departments
      • Acute Care Hospitals
      • Long-term Care Facilities
      • Outpatient Settings
      • Technology Overview
        • Table Market Value for Infection Prevention Equipment and Related Consumables by Product Type, 2016
      • Sterilization vs. Disinfection
    • Equipment and Solutions
      • Table Market Value for Infection Prevention Equipment and Related Consumables by Technology, 2016
    • Heat/Steam Sterilization
      • Product Examples
    • Chemical and Gas Sterilization
      • Disinfecting Agents and Medical Device Components
      • Sterilants
        • Table Summary of Advantages and Disadvantages of Chemical Agents Used as Chemical Sterilants or as High-Level Disinfectants
        • Table Comparison of the Characteristics of Selected Chemicals Used as High-Level Disinfectants or Chemical Sterilants
      • Product Examples
      • Mid-Level Disinfectants
        • Table Comparison of the Characteristics of Selected Hospital Disinfectants for General Disinfection of Environmental Surfaces
    • Radiation Sterilization
      • Product Examples
        • Table Developments, Healthcare Infection Prevention
    • Competitive Analysis
      • Table The Global Market for Hospital Infection Prevention (Sterilization/Disinfection), Leading Suppliers' Shares, Estimates for 2016
  • Infection Testing
    • Overview
    • Total Market Size and Forecast
      • Table The Global Market for Hospital Infection Testing/Diagnostics, 2010-2021
      • Healthcare Infection Testing Market by Geographical Region
        • Table The Global Market for Hospital Infection Testing/Diagnostics, Estimated Products Sales by Primary Geographic Region, 2010-2021
    • Testing for Nosocomial Infections
      • Drug-Resistance/Susceptibility Testing
      • Genotypic Methods
      • DNA Sequencing
      • Solid-phase Hybridization Techniques
      • Microarrays
      • Real-time Polymerase Chain Reaction Techniques
      • Phenotypic Methods
      • Phage-based Assays
      • Colorimetric Methods
      • The Nitrate Reductase Assay
      • Chromogenic Testing
        • Table Market Value for Nosocomial Infection Diagnostics by Class, 2016
    • Specific Serious Healthcare Infection Testing
      • Table Tested Samples, Pathogens Isolated by Infection Type Infection Type Isolated Pathogen Distribution (%)
      • Acinetobacter Baumannii
      • Carbapenem-resistant Enterobacteriaceae
      • Clostridium Difficile
      • Product Examples
      • Hospital-Acquired Pneumonia
      • Pseudomonas Aeruginosa
      • Staphylococcus Aureus
      • Ventilator-Associated Pneumonia
        • Table Significant Approvals for Detecting Serious Healthcare Infections
        • Table HAI Test Approvals* in the U.S. by Year and Type, 2000-2016
        • Table Distribution of Diagnostic Test Approvals with HAI Indications by Pathogen, All Approvals, 2000-2016
        • Table Market Value for Nosocomial Infection Diagnostics by Pathogen Target, 2016
    • Developments
      • Table Ongoing Developments, Healthcare Infection Testing
      • Table Pathogen/Infection Detection Trials by Type
    • Competitive Analysis
      • Table The Global Market for Hospital Infection Testing/Diagnostics Leading Suppliers' Shares Estimates for 2016
  • Infection Treatment
    • Overview
    • Total Market Size and Forecast
      • Table The Global Market for Hospital Infection Treatment, 2010-2021
      • Healthcare Infection Treatment Market by Geographical Region
        • Table The Global Market for Hospital Infection Treatment Estimated Products, Sales by Primary Geographic Region, 2010-2021
    • Principles of Anti-bacterial Therapy
      • Infecting Organism
      • Antibiotic Sensitivity Testing
      • Site of Infection
      • Host Defenses and Organ Function
      • Antibiotic Pharmacokinetics
      • Monitoring Therapy
    • Classifications of Antibacterial Products
      • Aminoglycosides
      • Carbapenems
      • Cephalosporins
      • Glycopeptides
      • Macrolides
      • Penicillins
      • Quinolones
      • Sulfonamides
      • Tetracyclines
    • Market Size and Sales Distribution by Antibiotic Class
      • Table Market Value for Nosocomial Infection Treatments by Class, 2016
      • Table Nosocomial Infection Drug Candidates by Class, 2016
    • Infections and Drug Resistance
      • Easing Approvals of Antibiotics
        • Table CDER NME NDAs/BLAs Filings and Approvals as of 12/9/15
    • Qualified Infectious Disease Program Designations
      • Causes of Drug Resistance
      • Drug Resistance in Select Populations
      • Treatment Guidelines
        • Table Antibiotics with Difficult Penetration
        • Table Market Value for Nosocomial Infection Treatments by Pathogen Target, 2016
    • New Developments
      • Table New Developments, Healthcare Infection Treatments, as of December 2016
      • Table Infection Treatments in Development by Phase, as of December 2016
      • Table Infection Treatment Drugs in Development by Route of Administration, as of December 2016
      • New Developments in Biotherapies for Infection Treatment
    • Competitive Analysis
      • Table The Global Market for Hospital Infection Treatment, Leading Suppliers' Shares, Estimated Share for HAIs for 2016
      • Table Select Treatment Options for Serious Bacterial Infections (Type, Brand, and Manufacturer)
      • Leading Products
        • Table Annual Sales of Select Antibacterial Products, 2016
  • Market Opportunities for Hospital Infection Control
    • Market Considerations
    • Market Overview
      • Table The Global Market for Hospital Infection Control, 2010-2021
      • Table The Global Market for Hospital Infection Control, Estimated Market Share by Segment, 2016
      • Healthcare-Acquired Infection Distribution by Setting
        • Table The Global Market for Hospital Infection Control Estimated Market Share by Facility Setting, 2016
        • Table The Global Market for Hospital Infection Control Estimated Market Share by Hospital Department, 2016
      • Healthcare Infection Control Market by Geographical Region
        • Table The Global Market for Hospital Infection Control, Estimated Products Sales by Primary Geographic Region, 2010-2021
        • Table The Global Market for Hospital Infection Control, Estimated Product Sales by Geographic Region, 2010-2021
        • Table The Global Market for Hospital Infection Control, Estimated Market Share by Geographic Region, 2016 (%)
      • Developed and Emerging Market Analysis
        • Table Developed vs. Emerging Markets
        • Table The Global Market for Hospital Infection Control, Estimated Market Share by Region, 2016 (%)
  • Company Profiles
    • Introduction
      • Table Global Markets for HAI by Participant and Segment (Infection Prevention, Infection Diagnostics, Infection Treatment): HAI Treatment Participants Show Strong Performance in 2016
    • 3M
      • Table 3M Company Corporate Summary
      • Company Overview
      • Company Performance
    • Abbott Laboratories
      • Table Abbott Laboratories Corporate Summary
      • Company Overview
      • Company Performance
    • AbbVie
      • Table AbbVie Corporate Summary
      • Company Overview
      • Company Performance
    • Advanced Sterilization Products
      • Table Advanced Sterilization Products Corporate Summary
      • Company Overview
      • Company Performance
    • Alere
      • Table Alere Corporate Summary
      • Company Overview
      • Company Performance
    • AstraZeneca
      • Table AstraZeneca Corporate Summary
      • Company Overview
      • Company Performance
    • Bayer
      • Table Bayer Corporate Summary
      • Company Overview
      • Company Performance
    • Becton, Dickinson and Company
      • Table Becton, Dickinson Corporate Summary
      • Company Overview
      • Company Performance
    • Belimed
      • Table Belimed Corporate Summary
      • Company Overview
      • Company Performance
    • bioMérieux S.A.
      • Table bioMérieux Corporate Summary
      • Company Overview
      • Company Performance
    • Cantel Medical Corp.
      • Table Cantel Medical Corporate Summary
      • Company Overview
      • Company Performance
    • Danaher Corporation
      • Table Danaher Corporate Summary
      • Company Overview
      • Company Performance
    • Ecolab, Inc.
      • Table Ecolab Corporate Summary
      • Company Overview
      • Company Performance
    • Getinge Group
      • Table Getinge AB Corporate Summary
      • Company Overview
      • Company Performance
    • GlaxoSmithKline plc
      • Table GlaxoSmithKline Corporate Summary
      • Company Overview
      • Company Performance
    • Merck & Co.
      • Table Merck Corporate Summary
      • Company Overview
      • Company Performance
    • Pfizer, Inc.
      • Table Pfizer Corporate Summary
      • Company Overview
      • Company Performance
    • Roche
      • Table F. Hoffman-La Roche, Ltd. Corporate Summary
      • Company Overview
      • Company Performance
    • Sakura Seiki Co., Ltd.
      • Table Sakura Seiki Corporate Summary
      • Company Overview
    • Steris plc
      • Table Steris Corporate Summary
      • Company Overview
      • Company Performance
    • TSO3, Inc.
      • Table TSO3 Corporate Summary
      • Company Overview
      • Company Performance
  • List of Participants
    • Table List of Participants